KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Assets Average (2016 - 2025)

Pacific Biosciences Of California (PACB) has 15 years of Assets Average data on record, last reported at $793.6 million in Q4 2025.

  • For Q4 2025, Assets Average fell 41.44% year-over-year to $793.6 million; the TTM value through Dec 2025 reached $793.6 million, down 41.44%, while the annual FY2025 figure was $1.0 billion, 32.0% down from the prior year.
  • Assets Average reached $793.6 million in Q4 2025 per PACB's latest filing, down from $814.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $2.0 billion in Q4 2021 and bottomed at $793.6 million in Q4 2025.
  • Average Assets Average over 5 years is $1.5 billion, with a median of $1.7 billion recorded in 2021.
  • Peak YoY movement for Assets Average: skyrocketed 538.16% in 2021, then tumbled 46.96% in 2025.
  • A 5-year view of Assets Average shows it stood at $2.0 billion in 2021, then fell by 11.26% to $1.8 billion in 2022, then increased by 1.63% to $1.8 billion in 2023, then dropped by 25.62% to $1.4 billion in 2024, then tumbled by 41.44% to $793.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $793.6 million in Q4 2025, $814.3 million in Q3 2025, and $843.1 million in Q2 2025.